Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Risedronate

Known as: Risedronsäure, RISE, 1-Hydroxy-2-(3-pyridyl)ethylidene diphosphonate 
A synthetic pyridinyl bisphosphonate agent. Risedronate binds to hydroxyapatite crystals in bone and inhibits osteoclast-dependent bone resorption… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
PURPOSE To report 36-month outcomes of RIDE (NCT00473382) and RISE (NCT00473330), trials of ranibizumab in diabetic macular edema… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Persistent use of glucocorticoid drugs is associated with bone loss and increased fracture risk. Concurrent oral… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2008
Review
2008
Guideline developers use a bewildering variety of systems to rate the quality of the evidence underlying their recommendations… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
The effects of 7 years of risedronate treatment were evaluated in a second 2-year extension of a 3-year vertebral fracture study… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Changes in the level of biochemical markers of bone resorption with risedronate treatment for osteoporosis were examined as a… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Risedronate increases bone mineral density in elderly women, but whether it prevents hip fracture is not known… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Abstract: The purpose of this randomized, double-masked, placebo-controlled study was to determine the efficacy and safety of… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Abstract. Men and women (n = 518) receiving moderate-to-high doses of corticosteroids were enrolled in two studies with similar… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
1999
Highly Cited
1999
CONTEXT Risedronate, a potent bisphosphonate, has been shown to be effective in the treatment of Paget disease of bone and other… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 4
Is this relevant?
Highly Cited
1999
Highly Cited
1999
OBJECTIVE Risedronate, a new pyridinyl bisphosphonate, is a potent antiresorptive bone agent. This study examines the safety and… Expand
Is this relevant?